TipRanks
Go Ultimate55% OFF

Daniel Abdun-Nabi Insider Profile

11 Followers

Daniel Abdun-Nabi, Director at Aptevo Therapeutics, holds 400.00 shares in Aptevo Therapeutics (Ticker: APVO), holds 144.55K shares in Emergent Biosolutions (Ticker: EBS), holds ― shares in RegenXBio (Ticker: RGNX).

Daniel Abdun-Nabi's Trading History

APVO
Aptevo Therapeutics
Aug 10, 2026DirectorUninformative Buy1.63K$536.00
EBS
Emergent Biosolutions
Mar 04, 2019CEO, DirectorUninformative Sell846.23K$984.41K
RGNX
RegenXBio
―Director――

You May Also Like

Daniel Abdun-Nabi insider profile FAQ

What is the percentage of profitable transactions made by Daniel Abdun-Nabi?
The percentage of profitable transactions made by Daniel Abdun-Nabi is 67%.
What is the average return per transaction made by Daniel Abdun-Nabi?
The average return per transaction made by Daniel Abdun-Nabi is 9.80%.
What stocks does Daniel Abdun-Nabi hold?
Daniel Abdun-Nabi holds: APVO, EBS, RGNX stocks.
What was Daniel Abdun-Nabi’s latest transaction?
Daniel Abdun-Nabi’s latest transaction was an Uninformative Buy of $1.63K.
What was Daniel Abdun-Nabi's most profitable transaction?
Daniel Abdun-Nabi’s most profitable transaction was an Informative Buy of EBS stock on December 29, 2014. The return on the trade was 45.10%.
What is Daniel Abdun-Nabi's role in Aptevo Therapeutics?
Daniel Abdun-Nabi's role in Aptevo Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.